Insomnia Treatment: Ambien, Trazodone & Sleep Medication Guide

1. U.S. Food and Drug Administration (FDA) - Risk of Next-Morning Impairment After Use of Insomnia Drugs

FDA information concerning next-morning impairment associated with zolpidem and recommendations intended to reduce this risk.

https://www.fda.gov/drugs/drug-safety-and-availability/questions-and-answers-risk-next-morning-impairment-after-use-insomnia-drugs-fda-requires-lower

Clinical and Regulatory Note

Medication information is based on authoritative U.S. sources available at the time this article was last updated. Prescribing information, safety recommendations, and regulatory requirements can change.

Patients should consult an appropriately licensed healthcare professional regarding their individual circumstances. Treatment and prescribing decisions remain with the appropriately licensed healthcare professional.